- Visibility 409 Views
- Downloads 351 Downloads
- Permissions
- DOI 10.18231/j.ijoas.2025.010
-
CrossMark
- Citation
Olfactory dysfunction and quality of life changes in allergic rhinitis: impact of medical therapy: A prospective observational study
Background: Allergic rhinitis is one of the most common and undertreated diseases worldwide and persists throughout life. It is prevalent among 0.8 to 38.7% of the global population and many patients with allergic rhinitis have developed olfactory dysfunction. This study aimed to assess the olfactory function and quality of life changes before and after medical therapy.
Aim: A clinical assessment of olfactory function and quality of life changes in patients with allergic rhinitis before and after medical therapy.
Objectives: 1.To assess the prevalence of olfactory dysfunction in patients diagnosed with allergic rhinitis 2.To evaluate associated quality–of–life changes in patients diagnosed with allergic rhinitis.
Materials and Methods: A prospective observational study was conducted to assess the olfactory disfunction and the quality of life changes in the patient with allergic rhinitis before and after medical therapy over a period of 18 months(Jan 2013–Jul 2024) .A total of 300 patients diagnosed with Allergic rhinitis were taken into the study and were categorized based on ARIA(Allergic rhinitis and its impact on Asthma) classification (mild intermittent, mild persistent, moderate-to-severe intermittent, moderate-to severe persistent). Olfactory function was assessed using butanol threshold testing, and Quality of life was evaluated with the Rhino conjunctivitis Quality of Life Questionnaire (RQLQ) before and after 12 weeks of pharmacotherapy.
Results: Olfactory dysfunction was prevalent in 31.3% of patients (23.3% hyposmia, 8% anosmia), with sneezing (81.7%) as the primary symptom. Age group 31-40 (32.7%) and males (67%) were most affected. Post-treatment olfactory function improved significantly across all AR (allergic Rhinitis) categories (p < 0>
Conclusion: AR is associated with significant olfactory dysfunction, which, along with Quality of life, improves markedly with 12 weeks of medical therapy.
Keywords: Allergic rhinitis, Hyposmia, Quality of life.
References
- Akhouri S, House SA. Allergic Rhinitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
- Brożek JL. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol . 2017;140(4):950–8.
- Guss J. Olfactory dysfunction in allergic rhinitis. ORL J Oto-Rhino- Laryngol Its Relat Spec. 2009;71(5):268–72.
- Sara KB. Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis. Indian J Med Res. 2022;155(3–4):373–9.
- Hong SN, Clinical Manifestations of Allergic Rhinitis by Age and Gender: A 12-Year Single-Center Study. Ann Otol Rhinol Laryngol. 2020;129(9):910–7.
- Zheng M. Prevalence of allergic rhinitis in rural and urban populations. 2018 Akhouri S, House SA. Allergic Rhinitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Feb 23]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK538186/
- Quillen DM, Feller DB. Diagnosing Rhinitis: Allergic vs. Nonallergic. Am Fam Physician. 2006;73(9):1583–90.
- Stuck BA, Hummel T. Olfaction in allergic rhinitis: A systematic review. J Allergy Clin Immunol. 2015;136(6):1460–70.
- Fornazieri MA, Garcia ECD, Montero RH, Borges R, Bezerra TFP, Pinna FR. Prevalence and Magnitude of Olfactory Dysfunction in Allergic Rhinitis. Am J Rhinol Allergy. 2024;38(5):306-15.
- Cowart BJ, Flynn-Rodden K, McGeady SJ, Lowry LD. Hyposmia in allergic rhinitis. J Allergy Clin Immunol. 1993;91(3):747–51.
- Fornazieri MA, Garcia ECD, Montero RH, Borges R, Bezerra TFP, Pinna FR. Prevalence and Magnitude of Olfactory Dysfunction in Allergic Rhinitis. Am J Rhinol Allergy. 2024;38(5):306–15.
- Sara KB, Rupa V, Jeyaseelan L. Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis. Indian J Med Res. 2022;155(3-4):373–
- Stuck BA, Hummel T. Olfaction in allergic rhinitis: A systematic review. J Allergy Clin Immunol. 2015;136(6):1460–70.
- Sara KB, Rupa V, Jeyaseelan L. Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis. Indian J Med Res. 2022;155(3-4):373–
How to Cite This Article
Vancouver
Madabhushi R, Longchar CI, Mounika C, Dandaboina K. Olfactory dysfunction and quality of life changes in allergic rhinitis: impact of medical therapy: A prospective observational study [Internet]. J Otorhinolaryngol Allied Sci. 2025 [cited 2025 Oct 05];8(2):39-43. Available from: https://doi.org/10.18231/j.ijoas.2025.010
APA
Madabhushi, R., Longchar, C. I., Mounika, C., Dandaboina, K. (2025). Olfactory dysfunction and quality of life changes in allergic rhinitis: impact of medical therapy: A prospective observational study. J Otorhinolaryngol Allied Sci, 8(2), 39-43. https://doi.org/10.18231/j.ijoas.2025.010
MLA
Madabhushi, Ramasridhar, Longchar, C. Imlirenla, Mounika, Ch, Dandaboina, Karthik. "Olfactory dysfunction and quality of life changes in allergic rhinitis: impact of medical therapy: A prospective observational study." J Otorhinolaryngol Allied Sci, vol. 8, no. 2, 2025, pp. 39-43. https://doi.org/10.18231/j.ijoas.2025.010
Chicago
Madabhushi, R., Longchar, C. I., Mounika, C., Dandaboina, K.. "Olfactory dysfunction and quality of life changes in allergic rhinitis: impact of medical therapy: A prospective observational study." J Otorhinolaryngol Allied Sci 8, no. 2 (2025): 39-43. https://doi.org/10.18231/j.ijoas.2025.010